Skip to main content
    N

    Nutex Health Inc (NUTX)

    Official site

    HEALTHCARE • MEDICAL CARE FACILITIES • NASDAQ

    $169.70
    -3.97 (-2.29%)

    Market Cap: $1.19B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Nutex Health Inc (NUTX) Financials: Revenue, Profit and Cash Flow

    Updated Nov 5, 2026. Financial statements from company filings, amounts in US dollars.

    Nutex Health reported revenue of $875.26M for the fiscal year ended Dec 31, 2025, up 82.4% from the year before. That year, net income was $180.36M with a net margin of 20.6%, operating cash flow was $248.13M and free cash flow was $245.60M. The quarter ended Sep 30, 2026 had revenue of $217.61M and net income of $57.34M.

    Revenue and Margins

    The operating margin was 31.5% in the fiscal year ended Dec 2025. Over the 8 years to Dec 2025, revenue grew from $53.65K, a compound annual rate of 236.2%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$875.26M+82.4%50.8%31.5%20.6%
    Dec 2024$479.95M+93.8%40.9%27.2%19.8%
    Dec 2023$247.65M+12.9%14.0%-12.8%-17.5%
    Dec 2022$219.29M-33.9%7.0%-185.4%-197.3%
    Dec 2021$331.53M+21.0%54.1%51.4%50.8%
    Dec 2020$274.03M+19954.5%57.5%55.9%53.1%
    Dec 2019$1.37M+1395.4%39.2%-504.8%-520.8%
    Dec 2018$91.37K+70.3%31.8%-2003.4%-3080.0%
    Dec 2017$53.65KN/A100.0%-10611.8%1085.0%
    Dec 2016N/AN/AN/AN/AN/A
    Annual, fiscal years ended Dec 2016 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, net income rose 90.2% from the year before. In the quarter ended Sep 2026, net income fell 40.8% from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Revenue$875.26M$479.95M$247.65M$219.29M$331.53M$274.03M$1.37M$91.37K$53.65KN/A
    Cost of revenue$175.32M$132.81M$122.53M$123.90M$106.04M$10.48M$830.44K$62.30K$564.37K$473
    Gross profit$444.28M$196.26M$34.77M$15.42M$179.28M$157.61M$535.98K$29.07K$53.65K-$473
    Research and development$0$0$0$0$0$0$768.10K$0$0$0
    Operating income$275.63M$130.70M-$31.77M-$406.60M$170.26M$153.17M-$6.90M-$1.83M-$5.69M-$448.60K
    Net income$180.36M$94.81M-$43.42M-$432.74M$168.53M$145.56M-$7.12M-$2.81M$582.06K-$7.43M
    EBITDA$287.54M$148.73M-$14.58M-$394.03M$183.35M$158.07M-$6.73M$0$0$0
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$217.61M$210.75M$216.49M$151.68M$267.80M$243.99M$211.79M$257.62M$78.80M$76.08M$67.45M$69.67M
    Gross profit$101.53M$141.28M$91.73M$46.14M$154.88M$124.92M$118.34M$141.63M$21.92M$22.56M$10.16M$13.21M
    Operating income$77.10M$121.72M$81.27M$30.92M$130.37M$33.68M$80.66M$114.29M$9.66M$5.30M$1.45M-$26.15M
    Net income$57.34M$96.32M$62.76M$16.61M$96.80M$16.14M$50.81M$99.50M-$7.17M$3.01M-$542.00K-$27.71M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, cash and equivalents exceeded total debt of $43.25M by $142.32M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Total assets$918.52M$655.32M$398.25M$431.75M$394.65M$169.86K$6.69M$449.43K$3.33M$510.83K
    Current assets$538.81M$292.48M$90.85M$97.97M$154.02M$157.06K$1.24M$305.42K$55.08K$507.93K
    Cash and equivalents$185.57M$40.64M$22.00M$34.26M$36.12M$26.93K$1.07M$119.27K$9.45K$10.52K
    Total liabilities$495.09M$466.79M$319.14M$311.42M$203.07M$1.30M$4.83M$1.95M$959.78K$6.38M
    Short-term debt$14.08M$17.95M$14.18M$15.17M$10.23M$312.89K$2.48M$477.06K$386.19K$50.00K
    Long-term debt$29.17M$22.47M$26.31M$23.05M$78.82M$150.00K$0N/AN/AN/A
    Shareholder equity$329.45M$132.44M$61.45M$95.86M$114.65M-$1.13M$1.86M-$1.50M$2.37M-$5.87M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$1.03B$964.63M$957.32M$918.52M$964.52M$841.03M$761.92M$655.32M$438.49M$422.40M$404.28M$398.25M
    Total liabilities$491.47M$457.32M$515.26M$495.09M$526.49M$504.15M$506.65M$453.43M$358.71M$340.38M$324.27M$319.14M
    Cash and equivalents$249.91M$205.21M$207.35M$185.57M$166.05M$96.73M$84.73M$43.58M$46.91M$40.81M$30.01M$22.00M
    Shareholder equity$435.57M$394.32M$346.29M$329.45M$317.17M$235.25M$176.95M$146.34M$60.44M$62.73M$63.02M$61.45M
    Last 12 quarters

    Cash Flow

    In the fiscal year ended Dec 2025, free cash flow was 99.0% of operating cash flow. Dividends and share repurchases together came to 32.3% of it.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Operating cash flow$248.13M$23.15M$1.26M$50.61M$173.43M$86.67M-$4.04M-$480.05K-$714.62K-$274.22K
    Capital expenditures$2.53M$2.30M$9.50M$14.63M$36.93M$61.19M$84.00K$0$0$0
    Free cash flow$245.60M$20.85M-$8.24M$35.97M$136.51M$25.48M-$4.12M-$480.05K-$714.62K-$274.22K
    Dividends paid$74.28M$6.44M$5.21M$51.23M$144.34M$59.05M$18.90MN/AN/AN/A
    Share repurchases$5.00M$0$0N/AN/AN/AN/AN/AN/AN/A
    Investing cash flow-$5.24M-$5.61M-$11.24M-$4.34M-$36.98M-$61.19M-$748.20K-$116.96K$2.05K-$9.99K
    Financing cash flow-$97.95M$1.09M-$2.27M-$48.13M-$125.85M-$7.97M$5.73M$704.57K$711.50K$172.44K
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow$78.35M$34.20M$75.52M$70.39M$99.51M$27.26M$50.97M$54.00K$6.79M$13.26M$3.05M-$1.78M
    Capital expenditures$5.20M$2.54M$1.20M$1.41M$302.00K$751.00K$64.00K$395.00K$617.00K$559.00K$733.00K$825.49K
    Free cash flow$73.14M$31.66M$74.32M$68.98M$99.21M$26.51M$50.90M-$341.00K$6.17M$12.70M$2.32M-$2.60M
    Last 12 quarters

    Frequently Asked Questions About NUTX

    What is Nutex Health's annual revenue?

    Nutex Health reported revenue of $875.26M for the fiscal year ended Dec 31, 2025.

    How fast is Nutex Health's revenue growing?

    Revenue was up 82.4% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 58.6%.

    Is Nutex Health profitable?

    Yes. Nutex Health reported net income of $180.36M for the fiscal year ended Dec 31, 2025, with a net margin of 20.6%.

    How much free cash flow does NUTX generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of $248.13M minus capital expenditures of $2.53M produced free cash flow of $245.60M.

    How much debt does Nutex Health have?

    The balance sheet dated Dec 31, 2025 reported long-term debt of $29.17M, short-term debt of $14.08M and cash and equivalents of $185.57M.